Medpace Breast Cancer Awareness Month Highlights
In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women in the United States during her lifetime, and a staggering 2.3 million women a year worldwide.
At Medpace, we have conducted hundreds of solid tumor studies and are proud to have contributed to many of the latest cancer therapies applied to breast cancer patients utilized today. Our success as a leading Oncology CRO is rooted in our unwavering commitment to applying our expertise in oncology, radiation oncology, and imaging, customized to meet the unique demands of each cancer project.
Medpace’s Global Acknowledgement of Breast Cancer Awareness Month
Medpace associates honored all those affected by breast cancer by turning it’s global offices pink.
Beyond Awareness: Discover Medpace’s Impact in Breast Cancer Clinical Research in Newly-Released Webinar
In our latest webinar, Dr. Jess Guarnaschelli, Senior Medical Director, Radiation Oncologist at Medpace, offers a comprehensive overview of the groundbreaking 2023 Breast Cancer Research Highlights, paying homage to Breast Cancer Awareness Month.
With over a decade of experience caring for adult breast cancer patients, Dr. Guarnaschelli’s passion for her work at Medpace is unparalleled. “We’re proud to have contributed to many of the latest therapies applied to breast cancer used today,” says Dr. Guarnaschelli.
Learn more about Medpace’s experience in: